Thermo Fisher receives AIFA’s GMP approval for manufacturing facility of RNA-based products in Italy
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
This product has sales of about US$ 20 million in Europe
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
The Institute is catering the health needs of the surrounding population with ever-increasing OPD every year along with special OPDs like mother & Child OPD, and LSD clinic
Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway
The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
Lays Foundation Stone of 6 new facilities at AIIMS Bhopal and inaugurates a slew of facilities in Madhya Pradesh
Base4's drug discovery platform allows its collaborators to evaluate billions of novel small molecules to identify and progress RNA-modulators for important diseases
Subscribe To Our Newsletter & Stay Updated